We are live on ! Find out more
MAM

MPM Asset Management Portfolio holdings

AUM $44.5M
1-Year Est. Return 47.28%
This Fund
S&P 500
This Quarter Est. Return
-22.77%
1 Year Est. Return
-47.28%
3 Year Est. Return
+5.89%
5 Year Est. Return
-18.52%
10 Year Est. Return
+3.53%
AUM
$164M
AUM Growth
-$62.8M
Cap. Flow
-$609K
Cap. Flow %
-0.37%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$609K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HARP
1
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$52.4M 31.87%
452,443
RYTM icon
2
Rhythm Pharmaceuticals
RYTM
$7.38B
$35.9M 21.85%
2,359,463
-34,034
-1% -$609K
TCRR
3
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$31.4M 19.07%
4,050,865
SNDX icon
4
Syndax Pharmaceuticals
SNDX
$1.74B
$23.8M 14.47%
2,168,691
CHMA
5
DELISTED
Chiasma, Inc. Common Stock
CHMA
$20.9M 12.74%
5,736,296

Similar funds

MPM Asset Management's Q1 2020 Portfolio in Review

As of Q1 2020, MPM Asset Management held 5 positions worth $164M, down 28% from $227M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2020: portfolio turnover was 0%. MPM Asset Management opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • MPM Asset Management's biggest Q1 2020 reduction was Rhythm Pharmaceuticals, cutting an estimated $609K.
  • MPM Asset Management's ten largest holdings make up 100% of its $164M portfolio in Q1 2020.
  • MPM Asset Management opened 0 new positions and closed 0 in Q1 2020.
  • MPM Asset Management's portfolio value fell 28% quarter-over-quarter to $164M.

Based on MPM Asset Management's 13F filing for Q1 2020, filed 13 May 2020.